Progen Pharmaceuticals Limited

46 articles about Progen Pharmaceuticals Limited

• Salix Pharmaceuticals, Ltd., Progen Pharmaceuticals Limited Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012

  4/25/2012

• Progen Pharmaceuticals Limited Receives Delisting Notification from The Nasdaq Stock Market -- New York

  6/24/2010

• KAI Pharmaceuticals, Inc. Acquires Patents from Progen Pharmaceuticals Limited, Broadening KAI's Intellectual Property Estate Covering Peptide-Based Therapies

  6/30/2009

• Progen Pharmaceuticals Limited Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth

  4/21/2009

• Avexa Limited's Proposed Merger With Progen Pharmaceuticals Limited Terminated

  3/10/2009

• Progen Pharmaceuticals Limited Concedes Shareholder Requisitioned Meeting

  2/19/2009

• Avexa Limited And Progen Pharmaceuticals Limited Merger Update

  2/11/2009

• Cytopia Limited and Other Progen Pharmaceuticals Limited Shareholders Maintain Call for Meeting

  2/9/2009

• Progen Pharmaceuticals Limited - Avexa Limited Merger Notice of Meeting and Independent Expert Report

  2/5/2009

• Progen Pharmaceuticals Limited - Avexa Limited Merger Update

  1/30/2009

• Cytopia Limited Release: Progen Pharmaceuticals Limited Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders

  1/29/2009

• Avexa Limited and Progen Pharmaceuticals Limited Merger Update

  1/5/2009

• Avexa Limited and Progen Pharmaceuticals Limited Agree to Merge in a $82 Million Deal

  12/22/2008

• Progen Pharmaceuticals Limited Receives NASDAQ Deficiency Notice

  9/8/2008

• Progen Pharmaceuticals Limited Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A

  7/24/2008

• Progen Pharmaceuticals Limited Launches PharmaSynth Manufacturing Unit

  7/8/2008

• Presentation of Data on Progen Pharmaceuticals Limited's Cancer Epigenetic Targets Platform At American Association for Cancer Research Epigenetics Meeting

  6/4/2008

• Progen Pharmaceuticals Limited Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047

  5/15/2008

• Progen Pharmaceuticals Limited PG500 Series Presented at the American Association for Cancer Research Annual Meeting in San Diego

  4/14/2008

• Progen Pharmaceuticals Limited Restructures Manufacturing and Drug Discovery Divisions; Axes Staff

  3/27/2008